Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Capitalization 26.46B 22.82B 20.61B 19.75B 35.89B 2,437B 37.53B 243B 97.57B 1,166B 99.31B 97.18B 4,184B P/E ratio 2026 *
28.2x
P/E ratio 2027 * 23.2x
Enterprise value 26.34B 22.72B 20.52B 19.66B 35.74B 2,426B 37.36B 242B 97.14B 1,161B 98.87B 96.75B 4,165B EV / Sales 2026 *
5.03x
EV / Sales 2027 * 4.35x
Free-Float
95.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.56%
1 week-7.76%
Current month-8.20%
1 month-1.10%
3 months-0.22%
6 months-11.30%
Current year+1.57%
1 week 66
Extreme 66
73.57
1 month 62.86
Extreme 62.86
74.49
Current year 62.86
Extreme 62.86
75.98
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer 49 30/09/2022
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Change 5d. change 1-year change 3-years change Capi.($)
-2.07%-7.76%-4.68%-37.45% 26.46B
-2.29%-2.95%-19.60%+13.90% 196B
-1.22%-6.72%-3.83%+17.58% 117B
-0.54%-2.96%+37.45%+140.31% 70.38B
+2.54%-3.06%+57.78%+92.66% 57B
+0.14%-5.74%-27.80%-28.51% 47.11B
+0.18%-1.93% - - 35.23B
-1.34%-7.96%-3.26%+26.19% 22.33B
+0.05%+1.47%-24.40%+13.88% 19.05B
+1.79%-1.08%-12.22%-46.23% 18.32B
Average -0.22%-5.19%-0.06%+21.37% 60.89B
Weighted average by Cap. -0.84%-4.20%-0.96%+30.69%

Financials

2026 *2027 *
Net sales 5.23B 4.51B 4.08B 3.91B 7.1B 482B 7.43B 48.14B 19.3B 231B 19.65B 19.23B 828B 5.88B 5.08B 4.58B 4.39B 7.98B 542B 8.35B 54.11B 21.7B 259B 22.09B 21.61B 930B
Net income 969M 835M 754M 723M 1.31B 89.23B 1.37B 8.91B 3.57B 42.68B 3.64B 3.56B 153B 1.19B 1.03B 926M 888M 1.61B 110B 1.69B 10.94B 4.39B 52.4B 4.46B 4.37B 188B
Net Debt -117M -101M -91.02M -87.23M -159M -10.76B -166M -1.07B -431M -5.15B -439M -429M -18.48B -886M -764M -690M -661M -1.2B -81.63B -1.26B -8.15B -3.27B -39.05B -3.33B -3.25B -140B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
10/03/26 67.92 $ -1.19% 682,943
09/03/26 68.74 $ +0.94% 4,072,596
06/03/26 68.10 $ -3.66% 3,930,660
05/03/26 70.69 $ -3.03% 5,099,895
04/03/26 72.90 $ -0.25% 4,340,679
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
68.74USD
Average target price
85.85USD
Spread / Average Target
+24.89%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW